Press release
Xerostomia Therapeutics Market 2019 Top Players are Acacia Pharma Limited, Colgate-Palmolive, Church & Dwight Co., Inc., GSK, Hikma Pharmaceuticals, Lupin Pharmaceuticals, PENDOPHARM, Pfizer, SUN PHARMA, Others – Forecast to 2026
Xerostomia Therapeutics Market
Get Free Sample of Global Xerostomia Therapeutics Market At: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-xerostomia-therapeutics-market
Xerostomia is a disease leading to oral dryness and are not easily diagnosed. Dryness of mouth is associated with the altered salivary gland functionality and other etiologies causing oral issues. Xerostomia caused due to the absence of saliva flow, and this is due to shrinkage of salivary gland. The xerostomia therapeutics helps to treat these symptoms associated with the dry mouth. The dry mouth symptoms impacts the life style quality of the patient and causes difficulty in the swallowing, chewing and speaking which can lead to the thick oral mucus, sleep disturbance and bad breathing.
Few of the major market competitors currently working in the xerostomia therapeutics market are
Acacia Pharma Group PLC,
Colgate-Palmolive,
Church & Dwight Co. Inc.,
GlaxoSmithKline PLC,
Hikma Pharmaceuticals PLC,
Lupin,
OraCoat,
Parnell Pharmaceuticals Inc.,
Pendopharm,
Pfizer Inc.,
Sun Pharmaceutical Industries Ltd,
Synedgen Inc.
Competitive Analysis: Global Xerostomia Therapeutics Market
The global xerostomia therapeutics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of xerostomia therapeutics market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Market Drivers:
• Rising geriatric population has increased the demand for these therapeutics as the elderly population have more symptoms of dry mouth
• Increase in use of prescription medications
Market Restraints:
• High cost of xerostomia therapeutics is acting as a major restraint for the market
• Lack of awareness of xerostomia in the developing and underdeveloped economies
Inquiry Before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-xerostomia-therapeutics-market
Key Developments in the Market:
• In October 2018, Synedgen Incand the subsidiary Prisyna, announced the launch of Moisyn for the treatment of xerostomia dry mouth.
• May 2018, Synedgen Inc. and the subsidiary Prisyna , received 510(k) clearance from the US Food and Drug Administration (FDA) to market its family of Moisyn products designed to treat xerostomia. The clearance of the drug from FDA will help the company to provide the Moisyn products to the patients for the treatment and can alleviate the dry mouth symptoms.
Reasons to Purchase this Report:
• Current and future of global xerostomia therapeutics market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Segmentation: Global Xerostomia Therapeutics Market
By Type
• Salivary Stimulants
• Salivary Substitutes
• Dentifrices
By Prescription Based
• OTC
• Prescribed
By Geography
• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa
Get Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-xerostomia-therapeutics-market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Xerostomia Therapeutics Market 2019 Top Players are Acacia Pharma Limited, Colgate-Palmolive, Church & Dwight Co., Inc., GSK, Hikma Pharmaceuticals, Lupin Pharmaceuticals, PENDOPHARM, Pfizer, SUN PHARMA, Others – Forecast to 2026 here
News-ID: 1703700 • Views: …
More Releases from Data Bridge Market Research
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size
The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness.
Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the…
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size
Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation…
Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size
The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent…
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into…
More Releases for Xerostomia
Xerostomia (Dry Mouth) Therapeutics Market Opportunities, Business Statistics Re …
The global xerostomia therapeutics market size is expected to reach USD 822.1 million by 2026 growing at a CAGR of 3.6% during the forecast period according to a new report published by Polaris Market Research.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=31976
Some of the leading companies in this market include Colgate-Palmolive Company, EUSA Pharma, GlaxoSmithKline plc, Forward Science, Mission Pharmacal Company, Eisai Inc., Ora Health Inc., Parnell Pharmaceuticals, Inc., Ora…
Global Xerostomia (Dry Mouth) Treatment Market Segmentation and Analysis Researc …
With recorded sales worth US$ 952.7 Bn in 2021, the global xerostomia (dry mouth) treatment market is expected to experience high growth over the coming years owing to increasing consumption of prescribed medicines globally. The xerostomia treatment market is estimated to expand at a CAGR of nearly 6.1% from 2022 to 2032.
Xerostomia is commonly known as dry mouth that occurs as a result of decreased or missing saliva because of…
Xerostomia Therapeutics Market Size - Forecasts to 2026
As per the research conducted by GME, the Xerostomia Therapeutics Market will grow with a CAGR value of 3.8 percent by 2026. Factors boosting demand growth include increasing prescription drug consumption, quick accessibility & cost-effectiveness of drugs, a rising elderly population demographic, and an uptick in the incidence of disorders such as Sjogren's syndrome, HIV, diabetes, and Alzheimer's disease, among others.
Browse 151 Market Data Tables and 111 Figures spread through…
Xerostomia - Market Insight, Epidemiology and Market Forecast - 2027
"Xerostomia - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Xerostomia epidemiology and market outlook for the 7MM.
Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Xerostomia Understanding and Treatment Algorithm
The market report provides the overview of the Xerostomia by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology and diagnostic methods. It also covers the detailed treatment approaches…
Xerostomia Market: Global Market Capacity, Production, Revenue by Regions till 2 …
Xerostomia Market report gives a far reaching investigation of the Xerostomia the Research of disease transmission, giving the chronicled and forecasted information for the 7MM during the estimate time frame from 2016-2027. The report covers detailed overview of Xerostomia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns, it also helps to recognize the growth opportunities in the 7MM with respect to the patient population.
Get Sample PDF of Xerostomia…
Xerostomia (Dry Mouth) Treatment Market Growth to be Stimulated by 2025
Xerostomia, commonly known as dry mouth, is defined as a condition resulting in the limited production of saliva or alteration in the saliva quality to retain the mouth wet. Xerostomia is normally caused due to a variety of factors such as side-effects from medication, dehydration, surgery, mouth bleeding, smoking, and irradiation of neck and head. The xerostomia is not classified as a disease but as symptoms of variable disorders. Xerostomia…
